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In acute ischemic stroke, the relationship between regional cerebral blood flow (CBF) and tissue injury has led to the 
widespread acceptance of perfusion-weighted imaging to 
define tissue at risk of infarction.1,2 Perfusion-weighted imag-
ing, using a variety of measures, has shown promise in predict-
ing tissue outcome3,4 and has led to the selection of patients for 
clinical trials based on presenting perfusion characteristics.1
The majority of studies using perfusion imaging have 
relied on metrics derived from contrast-based magnetic 
resonance imaging (MRI) or computed tomography, such as 
time-to-peak or T
max
, which correlate with CBF.1,5 These bio-
markers are used in clinical trials and clinical decision mak-
ing,4,6 but their relationship to pathophysiological processes 
is not always clear.7 Arterial spin labeling (ASL) is increas-
ingly used to measure perfusion in the context of acute isch-
emic stroke with the advantages that it is noninvasive, can be 
performed serially without repeated contrast administration 
without reference to renal function, and allows absolute CBF 
quantification.8,9 ASL is validated for measuring perfusion in 
acute stroke and compares favorably to conventional tech-
niques.9,10 Multiple postlabeling delay (PLD) ASL has been 
less widely used in stroke-imaging studies but improves abso-
lute quantification of CBF, even in the presence of delayed 
blood arrival times.10,11 The addition of vessel encoding 
attributes signal to the different feeding arteries and has the 
potential to further improve accuracy of CBF quantification 
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in regions supplied by multiple arteries without compromis-
ing signal-to-noise ratio.11
After the advent of thrombectomy, there is a need to 
improve our understanding of the relationships between vessel 
status, reperfusion, and tissue outcome.12 This study aimed to 
investigate the relationship between changes in absolute CBF 
and tissue outcome in patients with acute ischemic stroke.
Methods
Patients and Volunteers
Six healthy volunteers were recruited and imaged under an agreed 
technical development protocol approved by the institution’s 
Research Governance Office. Patients with ischemic stroke were 
recruited into a prospective observational cohort study regardless 
of age or stroke severity under research protocols agreed by the UK 
National Research Ethics Service committees (refs: 12/SC/0292 and 
13/SC/0362). Inclusion criteria for this analysis were the following: 
DWI lesion on presenting scan, presenting scan within 18 hours of 
symptom onset, patient or representative able to give a clear medi-
cal history and participate in the consent process, and age >18 years. 
Patients with a contraindication to MRI, lacunar stroke defined on 
DWI, or severely impaired conscious level (score >1 on question 1a 
of the National Institute for Health Stroke Scale) were excluded.
Imaging
All scans were acquired using a 3.0T Siemens Verio scanner (Siemens 
Healthcare, Erlangen, Germany). CBF was measured using a multiple 
PLD vessel-encoded pseudocontinuous ASL (VEPCASL) sequence.11 
The labeling plane was positioned ≈8 cm below the level of the circle 
of Willis, through the proximal V3 segment of the vertebral arteries. 
A single-shot echo-planar imaging readout was used, acquiring 24 
slices sequentially from inferior to superior to give whole brain cov-
erage (repetition time [TR]=4080 ms, echo time [TE]=14 ms, voxel 
size=3.4×3.4×4.5 mm). Volumes were acquired after a range of 6 
PLDs (0.25, 0.5, 0.75, 1, 1.25, and 1.5 seconds). Vessel encoding of 
the 4 arteries in the labeling plane was achieved by means of 8 paired 
encoding cycles in a range of orientations.11,13 Calibration scans were 
acquired using identical parameters to the VEPCASL sequence but 
without ASL or background suppression applied, to allow absolute 
CBF quantification and to correct for uneven spatial sensitivity. Total 
acquisition time for the ASL data was 5 minutes and 55 seconds.
Retrospective motion correction was applied using the MCFLIRT 
tool found in the Oxford Centre for Function MRI of the Brain 
(FMRIB)'s Software Library (FSL).14,15 Calculation of the perfusion 
signals arriving from each artery at each PLD was achieved using a 
maximum a posteriori approach to the general Bayesian framework 
for vessel-encoded data.13,16 A kinetic curve was fitted to the data for 
each feeding artery separately to estimate CBF and bolus arrival time 
with a corresponding variance using a variational Bayes approach.8,17 
The resulting vessel-specific CBF maps were summed to generate a 
map of the total CBF from all arteries.
Other scanning protocols included diffusion-weighted imaging (3 
directions, 1.8×1.8×2.0 mm, field of view [FoV]=240 mm, 4 aver-
ages, b=0 and 1000 s/mm2, TR=9000 ms, TE=98 ms, 50 slices, and 
acquisition time=2 minutes and 53 seconds) with apparent diffusion 
coefficient calculation; T1-weighted structural imaging (magneti-
zation prepared rapid acquisition gradient echo, 1.8×1.8×1.0 mm, 
FoV=228 mm, TR=2040 ms, TE=4.55 ms, and acquisition time=3 
minutes and 58 seconds); and T2-weighted turbo spin echo fluid 
attenuated inversion recovery (1.9×1.9×2.0 mm, FoV=240 mm, 
TR=9000 ms, and TE=96 ms).
Healthy volunteers were scanned 3 times—at time 0, at 24 hours, 
and at 1 week—and underwent 4 repetitions of the VEPCASL 
sequence at each scan time. Patients were imaged at presentation, 
2 hours, 24 hours, 1 week (3–9 days), and 1 month (14–42 days), 
whenever possible. Acute scans were defined where the presenting 
MRI scans were acquired within 6 hours of symptom onset. When 
intravenous thrombolysis was administered, the first MRI scan 
occurred during the infusion of alteplase.
Image Registration
Rigid body registration using FMRIB’s Linear Image Registration 
Tool (FLIRT) was used for within time point registration.14 Nonlinear 
registration of structural scans was used between time points to limit 
potential error introduced by subacute edema.15 Contralateral non-
ischemic masks were created after registration of the perfusion deficit 
masks to standard (MNI152) space, before reflection and registration 
back to native image space.
Definitions and Regions of Interest
In healthy volunteers, 6 regions of interest (ROIs), which were evenly 
distributed throughout the cerebral cortex, were derived from the 
Harvard-Oxford Atlas and registered into ASL image space. The 
regions chosen were insula, lateral occipital, middle temporal, parac-
ingulate, postcentral, and precentral.18
In stroke patients, infarction at presentation was defined using 
semiautomated delineation of apparent diffusion coefficient below 
an externally validated threshold of 620×10−6 mm2/s.19 At 24 hours, 
infarction was manually delineated using trace DWI (b=1000 s/mm2) 
and at 1 week using T2-weighted fluid attenuated inversion recovery 
imaging. ROIs were defined as follows:
1. Ischemic core: within both presenting and final infarct 
definitions.
2. Infarct growth: within the final infarct but not within the pre-
senting infarct, which was further divided into:
i.   Early infarct growth (infarct growth within the trace DWI 
infarct at 24 hours but not in the ischemic core); and
ii.  Late infarct growth (infarct growth not within the 24-hour 
lesion, but within the final infarct).
3. Peri-infarct: tissue that survived adjacent to the final infarct 
(within a dilated infarct mask [using a 3×3×3 voxel kernel], but 
not within the final infarct itself).
Within the ischemic core, diffusion lesion pseudonormalization 
was defined as regions within this ROI that had renormalized apparent 
diffusion coefficient values by 24 hours (>620×10−6 mm2/s). Patients 
were divided by reperfusion status using the Modified Treatment 
in Cerebral Ischemia Scale, with Modified Treatment in Cerebral 
Ischemia grades 2b and 3 representing reperfusion.4,20
Tissue segmentation of the presenting structural T1-weighted 
image using FMRIB’s Automated Segmentation Tool (FAST) defined 
gray matter partial volume estimates,21 which were registered into 
perfusion image space. Analyses were performed within gray mat-
ter masks with a partial volume estimate of ≥50%, where ASL CBF 
estimates are more reliable.
Correlation With Clinical Outcomes
To investigate the relationship between perfusion dynamics and 
clinical recovery, changes in CBF from presentation to the 24-hour 
and 1-week time points within the presenting perfusion deficit were 
compared with changes in National Institute for Health Stroke 
Scale scores. Perfusion deficits were defined using a threshold of 20 
mL/100 g/min to guide manual delineation of the region.
Statistics
Means and SD of CBF within the gray matter voxels of each ROI 
were extracted, and patient and voxelwise means and 95% confidence 
intervals were calculated. Repeatability within healthy volunteers and 
the contralateral ROIs of patients was quantified using the coefficient 
of variation (SD/mean) and ANOVA. Receiver-operating character-
istic curve analyses were performed to determine the utility of using 
VEPCASL-derived CBF at acute presentation (within 6 hours of 
symptom onset) in predicting infarction. Youden indices were used 
to estimate optimum CBF thresholds.22 Optimum CBF values to pre-
dict final infarction were used to estimate thresholds of ischemic core 
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nonreperfusers). To explore the effects of time of imaging on ability 
of CBF to predict infarction, patients were further divided into those 
imaged 0 to 3 and 3 to 6 hours.
Results
Six healthy volunteers and 40 consecutive patients were pro-
spectively enrolled and underwent serial VEPCASL imaging. 
Patient demographics are presented in Table.
Healthy Volunteers
The average gray matter perfusion of healthy volunteers was 
62±15 mL/100 g/min (mean±SD), range 40 to 78 mL/100 g/
min. The coefficient of variation between the 4 repeated mea-
sures of CBF at the same scan time point was 8.5%. Between 
scan time points, the coefficient of variation was 9.7% 
(ANOVA, P<0.001), was 16% between individuals (P<0.001), 
and was 15% between atlas regions (P<0.001). Regional CBF 
ranged from 50±4 mL/100 g/min in the post central gyrus to 
73±8 mL/100 g/min in the insula. Data are presented in Figure 
I in the online-only Data Supplement.
CBF Variability in Patients
Within the contralateral ROIs of patients, the weighted mean 
CBF was 52±42 mL/100 g/min (Figure 1). For patients with 
both presenting and 24-hour scans, 2-way ANOVA demon-
strated a significant effect of the individual patient on the con-
tralateral ROI values (ANOVA, 77% of variance, P=0.01) but 
a nonsignificant effect of the day of the scan (ANOVA, 8% 
of variance, P=0.06). Dynamic CBF values from the contra-
lateral ROIs of individual patients are presented in Figure II 
in the online-only Data Supplement. There was no effect of 
tissue-type plasminogen activator infusion or blood pressure 
on contralateral ROI values (P=0.95 and P=0.61).
CBF in the Ischemic Hemisphere of Patients
At a voxel level, analysis demonstrated a graduated severity 
of hypoperfusion within 6 hours of stroke onset (Figure 1, 
top). Ischemic core voxels had a lower mean perfusion at 
presentation (mean±SD, 17±23 mL/100 g/min) than that in 
the regions of early and late infarct growth (21±26 and 25±35 
mL/100 g/min, respectively; ANOVA, P<0.0001). Mean CBF 
in the peri-infarct ROI (29±30 mL/100 g/min) was less than 
that in the contralateral hemisphere (52±42 mL/100 g/min; 
t test, P<0.0001) but less severely hypoperfused than ROIs 
that infarcted (t test, P=0.002). Within the ischemic core, CBF 
values within regions of diffusion lesion pseudonormaliza-
tion had a lower CBF than the ischemic core as a whole (8±9 
mL/100 g/min; t test, P<0.0001).
At a patient level, mean CBF values showed a similar 
pattern to mean voxelwise ROI means (Figure 1, bottom; 
ANOVA, P=0.02). The variation in CBF values within and 
Table.  Demographic Data
Mean age (SD), y 75.8 (13.1)
Female sex, % 63
Thrombolysed, % 53
Previous stroke/TIA, % 35
Hypertension, % 58
Diabetes mellitus, % 10
Atrial fibrillation, % 38
Cigarette smoker (current), % 19
Median NIHSS (IQR) 13 (6–19)
Median onset to MRI (IQR), h:mm 3:22 (2:38–7:31)
mTICI 2b/3, % 63
IQR indicates interquartile range; MRI, magnetic resonance imaging; mTICI, 
modified Treatment In Cerebral Ischemia, where 2b/3 denotes reperfusion; NIHSS, 
National Institute for Health Stroke Scale; and TIA, transient ischemic attack.
Figure 1. Upper: Voxelwise mean cerebral blood flow (CBF) in 
each region of interest within 6 h of symptom onset (error bars, 
95% confidence interval). Lower: Patient-level mean CBF in each 
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between a given type of ROI resulted in considerable overlap 
of values measured.
Receiver-operating characteristic curve analysis of CBF 
generated an area under the curve (AUC) of 0.71 for predict-
ing final infarct using all patients scanned within 6 hours. 
Using only those patients with demonstrated reperfusion to 
predict the ischemic core generated a CBF threshold, defined 
by the Youden analysis, of 22 mL/100 g/min and AUC of 0.75. 
The optimum threshold for final infarction in nonreperfusers 
was 25 mL/100 g/min with an AUC of 0.72 (Figure III in the 
online-only Data Supplement). Subgroups of patients who 
were imaged at 0 to 3 and 3 to 6 hours had similar optimum 
thresholds and AUCs to the larger 0 to 6 hours cohort, except 
those who reperfused and were imaged before 3 hours, when 
the optimum threshold was 14 mL/100 g/min with an AUC of 
0.76 (Table I in the online-only Data Supplement).
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Serial CBF Measures
There was marked heterogeneity in the patterns of perfusion 
within identically defined ROIs between patients (Figure 2). 
Both sustained ischemia and reperfusion to varying degrees 
were seen in the ischemic core and early and late infarct 
growth ROIs. The only uniform pattern was seen in peri-
infarct ROIs, which by definition survived, where all patients 
demonstrated a CBF value of >20 mL/100 g/min by 24 hours. 
Examples of the dynamic changes in CBF within individual 
patients with differing degrees of reperfusion, together with 
example CBF data, can be seen in Figures 3 through 5. Where 
hyperemia was seen post reperfusion at 24 hours and 1 week, 
the CBF had returned to low or normal levels in all patient 
ROIs at 1 month (Figures 2 and 4).
Correlation With Clinical Outcomes
Increases in CBF within the presenting perfusion deficit by 
1 week predicted a reduction in National Institute for Health 
Stroke Scale score (r2=54%; P=0.03). No correlation was seen 
between presentation and 24 hours (P=0.9).
Discussion
Knowledge of perfusion dynamics partially explained tissue 
outcome in this cohort of patients with acute ischemic stroke. 
At presentation, mean voxelwise CBF measured using multi-
ple PLD VEPCASL was consistent with tissue outcome in the 
ROIs of patients. The absolute CBF values were comparable 
to those derived using contrast and radiolabeled techniques 
in both healthy individuals and patients with stroke.23–26 
A biologically plausible pattern was observed: ROIs that 
underwent infarction earliest had a lower presenting CBF 
than those of later infarct growth. For example, regions of 
ischemic core had the lowest blood flow at presentation, but 
within this ROI, the voxels that underwent diffusion pseudo-
normalization had lower still presenting CBF values. This 
phenomenon is thought to represent facilitated diffusion from 
early vasogenic edema and a more severe injury,27,28 and the 
CBF in this ROI was similar to cited thresholds of membrane 
failure (8 mL/100 g/min).29
Receiver-operating characteristic curve analyses at pre-
sentation demonstrated that the ability of CBF to predict 
final infarction was only fair. CBF thresholds were similar to 
those estimated using contrast techniques and with equivalent 
AUCs.30,31 There was only small improvement in the AUCs 
when those with and without reperfusion were considered 
separately, implying that knowledge of presenting CBF and 
a final reperfusion status is not sufficient to predict tissue 
outcome. Subdividing patients into those imaged before and 
after 3 hours did not improve CBF prediction of infarction 
but did identify a lower threshold for defining ischemic core 
in patients imaged before 3 hours. This is consistent with 
preclinical data describing increasing CBF thresholds for 
infarction over time.32 Factors that confound using a single 
CBF measurement to predict tissue fate include duration and 
degree of previous hypoperfusion, dynamics of reperfusion, 
tissue type, previous exposure to ischemia, ischemia–reperfu-
sion injury, and individual susceptibility to hypoperfusion,33–36 
along with measurement errors such as residual motion arti-
facts and insensitivity to delayed blood arrival.
At a patient level, this finding was borne out by the marked 
overlap of presenting CBF values in different ROIs, demon-
strated in Figure 1. A similar pattern of mean CBF values to 
that of the voxelwise analysis was seen across the different 
tissue outcomes. Again, a single CBF measurement to predict 
tissue outcome at presentation in an individual is not suffi-
cient, even with knowledge of final perfusion status.
The predominant source of variability in the measurement 
of CBF is the variation seen between individuals, as opposed 
to temporal variation within individuals and other factors 
including noise. This individual variation may reflect dif-
ferences in age,26 hypertension,37 and burden of preexisting 
cerebrovascular disease.26 This has implications when quan-
tifying CBF values relative to the contralateral hemisphere. 
Alternatively, systematic measurement bias that remained 
consistent across time points, such as anatomic factors affect-
ing labeling efficiency, tendency to move in the scanner, and 
Figure 3. Upper: Example cerebral blood flow (CBF) maps from 
a patient without reperfusion at presentation and 24 h, with 
superimposed regions of interest below (red, ischemic core and 
blue, infarct growth). Lower: Absolute CBF quantification in the 4 
regions of interest (red, ischemic core; blue, infarct growth; green, 
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variations in vascular anatomy, may have explained some of 
the observed interindividual variation. Although there was 
some variation over time in the contralateral ROIs of patients, 
CBF did not vary systematically between the presenting scan 
and at 24 hours, which might have been expected if diaschisis 
had a significant effect.38,39
Analysis in healthy volunteers showed small, but statisti-
cally significant, variations in CBF between individuals, day 
of scan, and region of the brain, comparable to other work.40 
These variations in healthy CBF values may explain some of 
the variations seen in patients. However, the magnitude of the 
variation in healthy volunteers was low and well within the 
recommended limits for variation in ASL studies (20%),41 and 
less than that seen in contrast-based perfusion MRI.42
Serial perfusion data within individuals emphasized that 
perfusion dynamics are consistent with tissue outcome in 
some, but not all, patients. Data in Figure 2 from identical 
ROIs across patients show that reperfusion characteristics are 
heterogeneous. In the peri-infarct ROIs, which represent tis-
sue that survives, CBF consistently recovers by 24 hours to 
a greater level than the thresholds for infarction. However, 
reperfusion is not sufficient for survival of ischemic tissue 
outside the ischemic core, demonstrated by the reperfusion 
observed in regions of infarct growth. It is likely that only 
early reperfusion will allow tissue survival, but even this may 
not be sufficient for recovery. Delayed tissue injury despite 
recanalization is well described,43 and measuring serial abso-
lute tissue perfusion may help to differentiate no-reflow phe-
nomena from ischemia–reperfusion injury.44
Increases in CBF within the presenting perfusion deficit 
correlated with clinical recovery at 1 week but not at 24 hours. 
The lack of correlation at 24 hours may be because the study 
is too small for these patient-level analyses. Additionally, the 
correlation at 1 week may have been emphasized by hyper-
emia in reperfusers at 1 week (Figure 4).
All ASL studies are limited by the challenges of measur-
ing late arriving blood and white matter perfusion. Even after 
using multiple PLD ASL techniques, it is not possible to dis-
tinguish late arriving blood from voxels with minimal CBF. 
Combined with effects of partial volume contamination from 
white matter and CSF, this may lead to systematical under-
estimation of CBF. Other limitations include data loss in this 
study, a combination of motion artifact and loss to follow-up, 
which is more likely to occur in severe stroke syndromes. 
Advances using prospective motion correction, improved 
acquisition techniques, and shorter imaging times may miti-
gate some of these sources of error in the future.
Figure 4. Upper: Example cerebral blood flow (CBF) maps from 
a patient with delayed reperfusion and localized hyperemia at 
presentation, 24 h, and 1 wk, with superimposed regions of inter-
est below (red, ischemic core and blue, infarct growth). Lower: 
Absolute CBF quantification in the 4 regions of interest (red, 
ischemic core; blue, infarct growth; green, peri-infarct; and black, 
contralateral).
Figure 5. Upper: Example cerebral blood flow (CBF) maps from 
a patient with partial reperfusion at presentation, 24 h, and 1 wk, 
with superimposed regions of interest below (red, ischemic core 
and blue, infarct growth). Lower: Absolute CBF quantification in 
the 4 regions of interest (red, ischemic core; blue, infarct growth; 
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Conclusions
This study explores the relationship between tissue-level per-
fusion and highly characterized tissue outcome in patients 
with acute ischemic stroke. Without using exogenous contrast, 
CBF values were derived that were consistent with other more 
invasive techniques. The ability to acquire serial data high-
lighted the heterogeneity of perfusion characteristics between 
individuals and the need for complementary information, 
including tissue susceptibility and metabolism, to fully under-
stand tissue fate in acute stroke.
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